The latest quarterly R&D expense is $10.24 Million with a QoQ Growth of -1.12%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $10.24M.
$10.24M
$10.24 Million
Q2 FY2026 · 2026-06-30
-1.12%
vs. $10.36M prior quarter
12
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $10.24M | -1.12% | +15.41% |
| Q1 FY2026Period end 2026-03-31 | $10.36M | +2.22% | +36.44% |
| Q4 FY2025Period end 2025-12-31 | $10.13M | +23.62% | +9.95% |
| Q3 FY2025Period end 2025-09-30 | $8.20M | -7.64% | +59.40% |
| Q2 FY2025Period end 2025-06-30 | $8.87M | +16.90% | +39.73% |
| Q1 FY2025Period end 2025-03-31 | $7.59M | -17.63% | +38.53% |
| Q4 FY2024Period end 2024-12-31 | $9.21M | +79.23% | +106.59% |
| Q3 FY2024Period end 2024-09-30 | $5.14M | -19.04% | +33.39% |
| Q2 FY2024Period end 2024-06-30 | $6.35M | +15.90% | N/A |
| Q1 FY2024Period end 2024-03-31 | $5.48M | +22.85% | N/A |
| Q4 FY2023Period end 2023-12-31 | $4.46M | +15.72% | N/A |
| Q3 FY2023Period end 2023-09-30 | $3.85M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.